Biolimus A9 Synthesis Temperature Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for synthesizing 40-O-derivatives of rapamycin, such as Biolimus A9, produce undesired by-products with non-polar properties, reducing yield and complicating purification due to modifications at reactive hydroxyl groups.
Innovation Solution
Controlling the temperature of the synthesis reaction between 25 °C to 55 °C when combining an organic solvent, an organic base compound, and a compound having the structure of Formula II with a triflate, significantly reduces the production of by-products, leading to higher yields and purities of Biolimus A9.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If existing synthesis methods are used for 40-O-derivatives of rapamycin, then the reaction proceeds at conventional temperatures, but undesired by-products are produced due to modifications at reactive hydroxyl groups, reducing yield and complicating purification
Solution Approach 1:
The patent applies parameter changes by controlling the reaction temperature within a specific range (25-55°C) to suppress unwanted side reactions at hydroxyl groups while maintaining the desired etherification reaction at the 40-O position. This temperature parameter optimization directly reduces by-product formation and improves product purity.
2Productivity
If existing synthesis methods are used for 40-O-derivatives of rapamycin, then the reaction proceeds without strict temperature control, but the yield is reduced due to by-product formation
Solution Approach 1:
The patent implements parameter changes through precise temperature control (25-55°C) that simultaneously improves both yield and purity. By maintaining temperature within this range, the reaction achieves high conversion to desired product while minimizing competing side reactions, thus resolving the contradiction between productivity and manufacturing precision.
3Ease of manufacture
If existing synthesis methods are used, then purification is simplified, but the process requires additional purification steps due to by-products with non-polar properties
Solution Approach 1:
The patent resolves this contradiction by using temperature parameter control (25-55°C) to prevent by-product formation in the first place. This preventive approach eliminates the need for additional purification steps, maintaining ease of manufacture while avoiding the complexity that would otherwise be required to separate non-polar by-products.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in a dramatic reduction of unwanted by-products, significantly improving the yield and purity of Biolimus A9, making the process more efficient and effective.
Implementation Method 1
combining in a reaction mixture an organic solvent, an organic base compound having a nitrogen heteroatom, a compound having the structure of Formula II and a compound having the structure of Formula III; maintaining the reaction mixture at a temperature of from 25 °C to 55 °C
Data Source
Figure 1
Figure 2
Figure 3A~3B
AI summary
The present invention provides improved processes for obtaining rapamycin derivatives including Biolimus A9.